Navigation Links
ViroPharma to Present at Two Upcoming Healthcare Conferences
Date:6/3/2008

EXTON, Pa., June 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Goldman Sachs 29th Annual Global Healthcare Conference at 4:00 P.M. PDT on Tuesday, June 10, 2008. The conference is being held at the Ritz-Carlton, Laguna Nigel in Dana Point, CA.

ViroPharma also announced that William Roberts, vice president, corporate communications of ViroPharma, will present at the Needham Seventh Annual Biotechnology and Medical Technology Conference at 8:00 A.M. EDT on Wednesday, June 11, 2008. The conference is being held at the New York Palace Hotel.

ViroPharma's presentations will be webcast live for investors through http://www.viropharma.com and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV) and Clostridium difficile. For more information on ViroPharma, visit the company's website at http://www.viropharma.com.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
2. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
3. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the BIO CEO & Investor Conference
6. ViroPharma Provides 2008 Outlook
7. ViroPharma to Present at Two Upcoming Healthcare Conferences
8. Exelixis Announces June 10 Webcast of Presentation at the Goldman Sachs 29th Annual Global Healthcare Conference
9. Presentation at the 14th International Conference on Prenatal Diagnosis and Therapy Highlights Biocepts I.D.Rh(D) Prenatal Diagnostic
10. iCAD to Present at Seventh Annual Needham and Company Biotechnology and Medical Technology Conference
11. VIA Pharmaceuticals to Present at Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... RESEARCH TRIANGLE PARK, N.C. , April 27, 2017 ... ) today announced that its Board of Directors authorized ... company,s common stock. This program will became effective immediately, ... may be made in the open market, accelerated share ... time as determined by United Therapeutics, management and in ...
(Date:4/27/2017)... ... April 27, 2017 , ... Oncolinx, a ... 43North Startup Competition, has truly taken their cancer research out of this world. ... experiments from Cape Canaveral to the International Space Station’s (ISS) U.S. National Laboratory, ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... provider for digital pathology, today announced their digital pathology technology has the potential ... provided by five medical centers in The Netherlands as part of the ...
(Date:4/27/2017)... ... 27, 2017 , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, ... LHON is a rare devastating genetic disease that leads to a sudden and rapid ... of 20 patients carrying 11778, 14484 and 3460 mutations and having experienced the onset ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):